DEVICE AND METHOD FOR ELECTROSURGERY

• US 20100185082A1
• Filed: 09/21/2009
• Published: 07/22/2010
• Est. Priority Date: 03/07/2003
• Status: Abandoned Application

• Current Assignee: Avent Incorporated (Avanos Medical, Inc.)
• Original Assignee: Baylis Medical Company Inc. (Boston Scientific Corporation)
• Inventors: LEFLER, Amy, HARRISON, Robert, CHANDRAN, Subashini, SHAH, Krishnan, GODARA, Neil
• Application Number:
  US12/563,699
• Publication Number:
  US 20100185082A1
• Time in Patent Office: Days
• US Class Current: 600/424
• CPC Class Codes: A61B 18/1477 Needle-like probes
• CPC Class Codes: A61B 2090/3966 Radiopaque markers visible in an X-ray image
• CPC Class Codes: A61B 6/506 for diagnosis of nerves
• CPC Class Codes: A61B 90/39 Markers, e.g. radio-opaque or breast lesions markers
• CPC Class Codes: A61N 1/06 for high-frequency therapy
• CPC Class Codes: A61N 1/36017 with leads or electrodes penetrating the skin
• CPC Class Codes: A61N 1/36021 for treatment of pain
• CPC Class Codes: A61N 1/40 Applying electric fields by inductive or capacitive coupling microwave apparatus A61N5/00; Applying radio-frequency signals

Abstract

A method and apparatus are disclosed for improving accuracy of placement of a cannula during delivery of electrical energy to neural structures. The apparatus includes a cannula operable to deliver electrical current where a portion of the cannula is electrically insulated and a portion of the cannula is exposed and electrically conductive. The cannula further includes a radiopaque marker located to differentiate the electrically insulated region from the electrically exposed region by allowing it to be more clearly delineated using fluoroscopy or other radiographic imaging techniques. The cannula may be used to treat pain by delivering energy to a neural structure.

Claims

1. A method for treating pain by delivering energy to a patient'"'"'s body, comprising:

(i) providing an electrically conductive radiopaque cannula comprising an electrically insulated region, an electrically exposed region and a radiopaque marker for distinguishing the insulated region from the exposed region;

(ii) identifying the radiopaque marker, distinguishing the insulated region from the exposed region and positioning the exposed region to locate said exposed region proximate a neural structure; and

(iii) delivering energy through the cannula to said neural structure to treat pain.

2. The method of claim 1, wherein the neural structure is located proximate to or within a facet joint of a patient'"'"'s spine.

3. The method of claim 1, wherein the energy is delivered directly to said neural structure to ablate said neural structure.

4. The method of claim 1, wherein step (ii) further comprises positioning said exposed region substantially parallel and adjacent to said neural structure.

5. The method of claim 1, wherein step (ii) further comprises visualizing one or more anatomical landmarks associated with a location of said neural structure to facilitate the positioning of said exposed region to locate said exposed region proximate to said neural structure.

6. The method of claim 1, wherein in step (iii) the energy is delivered to create a first lesion, and wherein said method further comprises:

(iv) determining the locations of a proximal end and of a distal end of the electrically exposed region;

(v) repositioning the cannula such that said distal end of said electrically exposed region is positioned substantially at the location in which said proximal end of said electrically exposed region had been determined to be located in step (iv); and

(vi) delivering energy through the cannula to said neural structure to create a second lesion.

7. The method of claim 1, wherein in step (iii) the energy is delivered to create a first lesion, and wherein said method further comprises the steps of:

(iv) determining the locations of a proximal end and of a distal end of the electrically exposed region;

(v) repositioning the cannula such that said proximal end of said electrically exposed region is positioned substantially at the location in which said distal end of said electrically exposed region had been determined to be located in step (iv); and

(vi) delivering energy through the cannula to said neural structure to create a second lesion.

8. The method of claim 1 wherein a position of said electrically insulated region, relative to said electrically exposed region, is fixed.

9. The method of claim 1 for allowing a user to determine the orientation of the cannula by visualizing the exposed region and the radiopaque marker.

10. A radiopaque cannula for insertion into a patient'"'"'s body, the cannula comprising:

a radiopaque and electrically conductive elongate member having a proximal end and a distal end and defining a lumen therebetween, the elongate member including an electrically exposed region and an electrically insulated region; and

a radiopaque marker associated with the elongate member, the radiopaque marker being visible under radiographic imaging and being located for distinguishing the exposed region from the insulated region.

11. The cannula of claim 10, wherein said radiopaque marker is located substantially adjacent a distal end of the insulated region.

12. The cannula of claim 10, wherein said radiopaque marker comprises a material selected from the group consisting of platinum, iridium, gold, silver, tantalum, palladium and alloys thereof.

13. The cannula of claim 10, wherein at least a portion of said distal end of said elongate member is bent.

14. The cannula of claim 10, wherein said distal end of said elongate member defines an aperture in communication with said lumen.

15. The cannula of claim 10, further comprising a lateral aperture in communication with said lumen.

16. The cannula of claim 10, wherein said cannula is operable to connect to an energy source.

17. The cannula of claim 10, wherein the electrically insulated region comprises a coating of an electrically insulating material disposed external to the elongate member along at least a portion of the elongate member.

18. The cannula of claim 17, wherein said electrically insulating material comprises a material selected from the group consisting of parylene, PET and PTFE.

19. The cannula of claim 10, wherein the marker is affixed to the elongate member by a laser weld.

20. The cannula of claim 10, wherein the radiopaque marker comprises a band that substantially completely circumscribes the elongate member.

21. The cannula of claim 10, wherein said radiopaque marker comprises a material of a greater radiopacity than the material comprising said elongate member.

22. The cannula of claim 10, wherein said elongate member is substantially rigid.

23. A cannula for insertion into a patient'"'"'s body, said cannula comprising:

an electrically conductive radiopaque elongate member comprising an electrically insulated region and an electrically exposed region; and

a means for improving radiographic visualization of at least a portion of said elongate member;

said means for improving radiographic visualization being located for distinguishing the exposed region from the insulated region.